Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660900 · ClinicalTrials.gov registry record
Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System
A clinical trial, sponsored by Ohio State University.
- Recruiting
- Registry status
- 270
- Enrollment target
NCT07660900: Recruiting study, sponsored by Ohio State University.
NCT07660900 is a clinical trial that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 270 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07660900 is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 270 participants
- Enrollment target
Study Summary
The purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during robotic-assisted surgery.
Primary Outcome
The primary endpoint will be the textbook recovery, which will be defined as chest tube removal within 48 hours post-surgery, based on absence of air leak, absence of major complications or mortality within 30 days, no chest tube reinsertion, no atrial fibrillation, early hospital discharge with length of stay \<3 days, and absence of readmission. The rates of textbook recovery will be compared between patients undergoing anatomic lung resection with or without Force Feedback instruments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2027-12-31 |
What NCT07660900 shows while recruiting
NCT07660900 is an observational study that tracks outcomes without assigning an intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07660900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07660900 about?
NCT07660900 is a clinical study titled "Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System". The purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during robotic-assisted surger...
What is the current status of trial NCT07660900?
This trial is currently recruiting. The enrollment target is 270 participants. The study started on 2025-09-05. Estimated completion is 2027-12-31.
Who is sponsoring clinical trial NCT07660900?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI